Open-label study to assess the safety, pharmacokinetics and pharmacodynamics of five oral insulin formulations in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 26 May 2010
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 26 May 2010 Results have been published in the journal Diabetes, Obesity and Metabolism, according to a Oramed Pharmaceuticals media release.
- 18 May 2007 New trial record.